Pasar al contenido principal

EFECTO DEL TRATAMIENTO CON HORMONA DE CRECIMIENTO SOBRE LA CONECTIVIDAD CEREBRAL Y LA ESTRUCTURA DE LAS AREAS RELACIONADAS CON EL TONO MUSCULAR EN ADULTOS CON SINDROME DE PRADER-WILLI

PI18/00734

•
Nombre agencia financiadora Instituto de Salud Carlos III
Acrónimo agencia financiadora ISCIII
Programa Programa Estatal de Fomento de la Investigación Científica y Técnica de Excelencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de Investigación en Salud
Año convocatoria 2018
Plan Estatal 2013-2016 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario FUNDACION PARC TAULI
Centro realización CORPORACION SANITARIA PARC TAULI

Resultados relacionados

Resultados totales (Incluyendo duplicados): 7
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Mapping alterations in the local synchrony of the cerebral cortex in Prader Willi syndrome

  • Blanco Hinojo, Laura, 1981-
  • Pujol Nuez, Jesús|||0000-0002-9946-4547
  • Martinez Vilavella, Gerard|||0000-0001-8948-4918
  • Giménez-Palop, Olga|||0000-0002-4526-6342
  • Casamitjana, Laia|||0000-0002-2274-3804
  • Cobo Gomez, Jesus Vicente|||0000-0002-2032-9343
  • Pareja, Rocío|||0000-0002-2828-2666
  • Esteba-Castillo, Susanna|||0000-0003-0414-0599
  • Deus Yela, Juan|||0000-0002-3305-2662
  • Caixàs i Pedragós, Assumpta|||0000-0001-8472-9189
Individuals with Prader Willi syndrome (PWS) often exhibit behavioral difficulties characterized by deficient impulse regulation and obsessive-compulsive features resembling those observed in obsessive-compulsive disorder. The genetic configuration of PWS aligns with molecular and neurophysiological findings suggesting dysfunction in the inhibitory gamma-aminobutyric acid (GABA) interneuron system may contribute to its clinical manifestation. In the cerebral cortex, this dysfunction is expressed as desynchronization of local neural activity. We used functional connectivity MRI to examine potential alterations in the local synchrony of the cerebral cortex in PWS. Whole-brain functional connectivity maps were generated using iso-distance average correlation (IDAC) measures in 22 patients with PWS and 22 control participants. Patients with PWS showed reduced local connectivity (weaker synchrony) in frontal areas, including the orbitofrontal cortex, ventral medial and lateral frontal regions, the anterior cingulate cortex, and sensory areas. The presence of obsessive-compulsive symptoms was significantly associated with the degree of functional structure alteration in part of the orbitofrontal and sensory cortices. In addition, abnormally heightened functional connectivity (stronger synchrony) was identified in the posterior cingulate cortex and the bilateral angular gyri, core components of the default mode network, with distance-dependent effects. Our findings of cortical synchrony alterations indicate a degree of overlap with the anatomy of the alterations previously observed in primary obsessive-compulsive disorder, while also suggesting the implication of GABAergic dysfunction in the pathophysiology of the disorder. Our observations may support the rational development of more specific therapeutic strategies in the treatment of behavioral disinhibition characteristic of PWS.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Glucagon stimulation test to assess growth hormone status in Prader-Willi syndrome

  • Casamitjana, Laia|||0000-0002-2274-3804
  • Giménez-Palop, Olga|||0000-0002-4526-6342
  • Corripio, Raquel|||0000-0003-3344-8269
  • Pareja, Rocío|||0000-0002-2828-2666
  • Berlanga Escalera, Eugenio|||0000-0002-9774-4051
  • Rigla, M.
  • Oliva, Joan Carles|||0000-0003-1273-2746
  • Caixàs i Pedragós, Assumpta|||0000-0001-8472-9189
Growth hormone deficiency (GHD) must be confirmed before starting treatment in adults with Prader-Willi syndrome (PWS). Most studies use the growth-hormone-releasing hormone plus arginine (GHRH-arginine) test. No data are available on the glucagon stimulation test (GST) in PWS. We compared the utility of fixed-dose (1 mg) GST versus GHRH-arginine test in diagnosing GHD. Adults and late adolescents with PWS underwent both tests on separate days. In the GHRH-arginine test, GHD was defined according to body mass index. In the GST, two cutoffs were analyzed: peak GH concentration < 3 ng/mL and < 1 ng/mL. For analyses, patients were divided into two groups according to body weight (≤ 90 kg and
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Hunger and satiety peptides, is there a pattern to classify patients with prader-willi syndrome?

  • Bueno, Marta|||0000-0001-9488-4553
  • Boixadera Planas, Ester|||0000-0002-3995-6750
  • Blanco Hinojo, Laura, 1981-
  • Esteba-Castillo, Susanna|||0000-0003-0414-0599
  • Giménez-Palop, Olga|||0000-0002-4526-6342
  • Torrents-Rodas, David|||0000-0003-0222-7770
  • Pujol Nuez, Jesús|||0000-0002-9946-4547
  • Corripio, Raquel|||0000-0003-3344-8269
  • Deus Yela, Juan|||0000-0002-3305-2662
  • Caixàs i Pedragós, Assumpta|||0000-0001-8472-9189
Hyperphagia is one of the main problems of patients with Prader-Willi syndrome (PWS) to cope with everyday life. The underlying mechanisms are not yet well understood. Gut-brain hormones are an interrelated network that may be at least partially involved. We aimed to study the hormonal profile of PWS patients in comparison with obese and healthy controls. Thirty adult PWS patients (15 men; age 27.5 ± 8.02 years; BMI 32.4 ± 8.14 kg/m), 30 obese and 30 healthy controls were studied before and after eating a hypercaloric liquid diet. Plasma brain-derived neurotrophic factor (BDNF), leptin, total and active ghrelin, peptide YY (PYY), pancreatic polypeptide (PP), Glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP) and amylin were determined at times 0, 30, 60 and 120. Cluster analysis was used. When considering all peptides together, two clusters were established according to fasting hormonal standardized concentrations. Cluster 1 encompassed most of obese (25/30) and healthy controls (28/30). By contrast, the majority of patients with PWS were located in Cluster 2 (23/27) and presented a similar fasting profile with hyperghrelinemia, high levels of leptin, PYY, GIP and GLP-1, compared to Cluster 1; that may reflect a dysfunction of these hunger/satiety hormones. When peptide behavior over the time was considered, PP concentrations were not sustained postprandially from 60 min onwards in Cluster 2. BDNF and amylin did not help to differentiate the two clusters. Thus, cluster analysis could be a good tool to distinguish and characterize the differences in hormone responses between PWS and obese or healthy controls.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Cerebellar dysfunction in adults with prader willi syndrome

  • Blanco Hinojo, Laura, 1981-
  • Casamitjana, Laia|||0000-0002-2274-3804
  • Pujol Nuez, Jesús|||0000-0002-9946-4547
  • Martinez Vilavella, Gerard|||0000-0001-8948-4918
  • Esteba-Castillo, Susanna|||0000-0003-0414-0599
  • Giménez-Palop, Olga|||0000-0002-4526-6342
  • Freijo Gutierrez, Valentin
  • Deus Yela, Juan|||0000-0002-3305-2662
  • Caixàs i Pedragós, Assumpta|||0000-0001-8472-9189
Severe hypotonia during infancy is a hallmark feature of Prader Willi syndrome (PWS). Despite its transient expression, moto development is delayed and deficiencies in motor coordination are present at older ages, with no clear pathophysiological mechanism yet identified. The di-verse motor coordination symptoms present in adult PWS patients could be, in part, the result of a common alteration(s) in basic motor control systems. We aimed to examine the motor system in PWS using functional MRI (fMRI) during motor challenge. Twenty-three adults with PWS and 22 matched healthy subjects participated in the study. fMRI testing involved three hand motor tasks of different complexity. Additional behavioral measurements of motor function were obtained by evaluating hand grip strength, functional mobility, and balance. Whole brain activation maps were compared between groups and correlated with behavioral measurements. Performance of the motor tasks in PWS engaged the neural elements typically involved in motor processing. While our data showed no group differences in the simplest task, increasing task demands evoked significantly weaker activation in patients in the cerebellum. Significant interaction between group and correlation pattern with measures of motor function were also observed. Our study provides novel insights into the neural substrates of motor control in PWS by demonstrating reduced cerebellar activation during movement coordination.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

One Year of Recombinant Human Growth Hormone Treatment in Adults with Prader-Willi Syndrome Improves Body Composition, Motor Skills and Brain Functional Activity in the Cerebellum

  • Casamitjana, Laia|||0000-0002-2274-3804
  • Blanco Hinojo, Laura, 1981-
  • Giménez-Palop, Olga|||0000-0002-4526-6342
  • Pujol Nuez, Jesús|||0000-0002-9946-4547
  • Martinez Vilavella, Gerard|||0000-0001-8948-4918
  • Esteba-Castillo, Susanna|||0000-0003-0414-0599
  • Pareja, Rocío|||0000-0002-2828-2666
  • Freijo Gutierrez, Valentin
  • Vigil Giménez, Laura|||0000-0002-0837-9524
  • Deus Yela, Juan|||0000-0002-3305-2662
  • Caixàs i Pedragós, Assumpta|||0000-0001-8472-9189
We compared body composition, biochemical parameters, motor function, and brain neural activation in 27 adults with Prader-Willi syndrome and growth-hormone deficiency versus age-and sex-matched controls and baseline versus posttreatment values of these parameters after one year of recombinant human growth hormone (rhGH) treatment. To study body composition, we analyzed percentage of fat mass, percentage of lean mass, and muscle-mass surrogate variables from dual X-ray absorptiometry. Biochemical parameters analyzed included IGF-I, glucose metabolism, and myokines (myostatin, irisin, and IL6). To explore muscle function, we used dynamometer-measured handgrip strength, the Timed Up and Go (TUG) test, and the Berg Balance Scale (BBS). To study brain activation, we acquired functional magnetic resonance images during three motor tasks of varying complexity. After one year of treatment, we observed an increase in lean mass and its surrogates, a decrease in fat mass, improvements in TUG test and BBS scores, and increased neural activation in certain cerebellar areas. The treatment did not significantly worsen glucose metabolism, and no side-effects were reported. Our findings support the benefits of rhGH treatment in adults with Prader-Willi syndrome and growth-hormone deficiency on body composition and suggest that it may also improve balance and brain neural activation.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

An Exploratory Analysis on the 2D:4D Digit Ratio and Its Relationship with Social Responsiveness in Adults with Prader-Willi Syndrome

  • Gámez, Sara
  • Cobo Gomez, Jesus Vicente|||0000-0002-2032-9343
  • Fernández-Lafitte, Meritxell
  • Coronas, Ramon|||0000-0003-4756-4746
  • Parra Uribe, Isabel|||0000-0002-3490-7386
  • Oliva, Joan Carles|||0000-0003-1273-2746
  • Àlvarez, Aida|||0000-0001-7991-7548
  • Esteba-Castillo, Susanna|||0000-0003-0414-0599
  • Giménez-Palop, Olga|||0000-0002-4526-6342
  • Corripio, Raquel|||0000-0003-3344-8269
  • Palao, Diego|||0000-0002-3323-6568
  • Caixàs i Pedragós, Assumpta|||0000-0001-8472-9189
Prader-Willi syndrome (PWS) is a genetic disorder produced by a lack of expression of paternally derived genes in the 15q11-13 region. Research has generally focused on its genetic and behavioral expression, but only a few studies have examined epigenetic influences. Prenatal testosterone or the maternal testosterone-to-estradiol ratio (MaTtEr) has been suggested to play an important role in the development of the 'social brain' during pregnancy. Some studies propose the 2D:4D digit ratio of the hand as an indirect MaTtEr measure. The relationship between social performance and MaTtEr has been studied in other neurodevelopmental conditions such as Autism Spectrum Disorder (ASD), but to our best knowledge, it has never been studied in PWS. Therefore, our study aims to clarify the possible existence of a relationship between social performance-as measured using the Social Responsiveness Scale (SRS)-and MaTtEr levels using the 2D:4D ratio. We found that, as a group, PWS individuals have shorter index and ring fingers than the control group, but no significant difference in the 2D:4D ratios. The 2D:4D ratio showed a correlation only with Restricted Interests and Repetitive Behavior Subscale, where a positive correlation only for male individuals with PWS was found. Considering only PWS with previous GH treatment during childhood/adolescence (PWS-GH), index and ring fingers did not show differences in length with the control group, but the 2D:4D ratio was significantly higher in the right or dominant hand compared to controls.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Growth Hormone (GH) Treatment Decreases Plasma Kisspeptin Levels in GH-Deficient Adults with Prader-Willi Syndrome

  • Giménez-Palop, Olga|||0000-0002-4526-6342
  • Casamitjana, Laia|||0000-0002-2274-3804
  • Corripio, Raquel|||0000-0003-3344-8269
  • Esteba-Castillo, Susanna|||0000-0003-0414-0599
  • Pareja, Rocío|||0000-0002-2828-2666
  • Albiñana, Néstor|||0000-0002-5400-2277
  • Rigla Cros, Mercedes|||0000-0002-6691-4871
  • Caixàs i Pedragós, Assumpta|||0000-0001-8472-9189
Obesity and growth hormone (GH)-deficiency are consistent features of Prader-Willi syndrome (PWS). Centrally, kisspeptin is involved in regulating reproductive function and can stimulate hypothalamic hormones such as GH. Peripherally, kisspeptin signaling influences energy and metabolic status. We evaluated the effect of 12-month GH treatment on plasma kisspeptin levels in 27 GH-deficient adult PWS patients and analyzed its relationship with metabolic and anthropometric changes. Twenty-seven matched obese subjects and 22 healthy subjects were also studied. Before treatment, plasma kisspeptin concentrations in PWS and obese subjects were similar (140.20 (23.5-156.8) pg/mL vs. 141.96 (113.9-165.6) pg/mL, respectively, p = 0.979)) and higher (p = 0.019) than in healthy subjects (124.58 (107.3-139.0) pg/mL); plasma leptin concentrations were similar in PWS and obese subjects (48.15 (28.80-67.10) ng/mL vs. 33.10 (20.50-67.30) ng/mL, respectively, p = 0.152) and higher (p < 0.001) than in healthy subjects (14.80 (11.37-67.30) ng/mL). After GH therapy, lean body mass increased 2.1% (p = 0.03), total fat mass decreased 1.6% (p = 0.005), and plasma kisspeptin decreased to levels observed in normal-weight subjects (125.1(106.2-153.4) pg/mL, p = 0.027). BMI and leptin levels remained unchanged. In conclusion, 12-month GH therapy improved body composition and decreased plasma kisspeptin in GH deficient adults with PWS. All data are expressed in median (interquartile range).